Mutual of America Capital Management LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 120,736 shares of the healthcare conglomerate's stock after selling 2,806 shares during the quarter. UnitedHealth Group makes up about 0.7% of Mutual of America Capital Management LLC's investment portfolio, making the stock its 14th largest holding. Mutual of America Capital Management LLC's holdings in UnitedHealth Group were worth $70,592,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in UNH. Tealwood Asset Management Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $2,905,000. Asset Planning Services Inc. LA ADV boosted its holdings in shares of UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate's stock valued at $7,288,000 after buying an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate's stock valued at $14,603,000 after acquiring an additional 3,006 shares during the period. Americana Partners LLC increased its stake in shares of UnitedHealth Group by 10.8% during the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate's stock valued at $11,914,000 after purchasing an additional 1,984 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. grew its stake in shares of UnitedHealth Group by 14.8% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate's stock worth $5,072,000 after buying an additional 1,283 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
UNH has been the subject of several analyst reports. Bank of America reduced their price target on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. UBS Group lowered their price objective on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a report on Wednesday, October 16th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a research note on Wednesday, October 16th. Finally, KeyCorp assumed coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They set an "overweight" rating and a $675.00 price objective for the company. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $615.53.
Check Out Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Price Performance
UNH traded down $0.92 during trading on Friday, hitting $592.23. 3,423,919 shares of the company traded hands, compared to its average volume of 3,119,612. The stock's 50-day simple moving average is $582.84 and its two-hundred day simple moving average is $549.52. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market cap of $545.02 billion, a PE ratio of 38.58, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts' consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the company earned $6.56 EPS. The company's quarterly revenue was up 9.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group's dividend payout ratio is currently 54.72%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.